Effects of various fibrates on serum alkaline phosphatase activity.
Ganotakis
Emanuel
E
Tsimihodimos
Vasilios
V
Bairaktari
Eleni
E
Rizos
Evagelos
E
Athyros
Vasilios
V
Seferiades
Constantinos
C
Elisaf
Moses
M
D000469:Alkaline Phosphatase / Q000096:biosynthesis* / Q000097:blood / Q000187:drug effects*; D001629:Bezafibrate / Q000008:administration & dosage; D002995:Clofibric Acid / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005260:Female; D011345:Fenofibrate / Q000008:administration & dosage; D058607:Fibric Acids; D015248:Gemfibrozil / Q000008:administration & dosage; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000008:administration & dosage*; D008297:Male; D012189:Retrospective Studies; D016896:Treatment Outcome
D058607:Fibric Acids; D000960:Hypolipidemic Agents; D002995:Clofibric Acid; D000469:Alkaline Phosphatase; C019304:ciprofibrate; D015248:Gemfibrozil; D011345:Fenofibrate; D001629:Bezafibrate